WALTHAM, Mass—Renaissance Health Care has changed its name to KidneyTel and received accreditation from two committees for kidney disease management, according to a news release.
The name change coincides with the company’s upcoming launch its new TeleHealth monitoring technology, according to Robert Farrell, KidneyTel’s president. KidneyTel is a wholly-owned subsidiary of Fresenius Medical Care North America.
In addition, the National Committee on Quality Assurance (NCQA) awarded Renaissance with “Full Accreditation Patient and Practitioner Oriented Disease Management for Chronic Kidney Disease.”
The company also received “Full Accreditation for compliance with Disease Management Standards,” from the Utilization Review Accreditation Committee (URAC) covering the condition of chronic kidney disease.
“Renaissance Health Care is very proud to receive full accreditation from these two prestigious accrediting bodies,” Farrell said. “These accreditations are a validation of the continuous quality improvements in technology, care integration processes, and evidence based medicine policies that Renaissance has put in place to improve the lives of patients with chronic kidney disease.”
